Invention Grant
US08853245B2 Orally bioavailable dabigatran prodrugs for the treatment of diseases
有权
口服生物可利用达比加群前体药物治疗疾病
- Patent Title: Orally bioavailable dabigatran prodrugs for the treatment of diseases
- Patent Title (中): 口服生物可利用达比加群前体药物治疗疾病
-
Application No.: US13556612Application Date: 2012-07-24
-
Publication No.: US08853245B2Publication Date: 2014-10-07
- Inventor: Bernd Clement , Joscha Kotthaus , Juerke Kotthaus , Dennis Schade
- Applicant: Bernd Clement , Joscha Kotthaus , Juerke Kotthaus , Dennis Schade
- Applicant Address: DE Schöfeld/Waltersdorf
- Assignee: Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
- Current Assignee: Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG
- Current Assignee Address: DE Schöfeld/Waltersdorf
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP11175230 20110725
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/4439 ; A61K9/10 ; A61K9/00 ; A61K45/06
Abstract:
The present invention relates to prodrug derivatives of dabigatran, their use in the treatment and/or prophylaxis of diseases, in particular thrombotic diseases, stroke, cardiac infarction and/or atrial fibrillation and cardiac arrhythmia, as well as oncological diseases of any pathogenesis.
Public/Granted literature
- US20130030023A1 ORALLY BIOAVAILABLE DABIGATRAN PRODRUGS FOR THE TREATMENT OF DISEASES Public/Granted day:2013-01-31
Information query
